Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665389 | SCV000789505 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2017-02-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001861743 | SCV002245557 | pathogenic | Qualitative or quantitative defects of dysferlin | 2021-07-09 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 550602). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu1518Argfs*24) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). |
Baylor Genetics | RCV003465440 | SCV004194179 | likely pathogenic | Miyoshi muscular dystrophy 1 | 2023-10-10 | criteria provided, single submitter | clinical testing |